ClinicalTrials.gov
ClinicalTrials.gov Menu

Glycaemic, Insulinaemic and Appetite Responses to Two Different Types of Porridge

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01222845
Recruitment Status : Completed
First Posted : October 18, 2010
Last Update Posted : May 2, 2012
Sponsor:
Information provided by (Responsible Party):
Javier Gonzalez, Northumbria University

Brief Summary:
The purpose of this study is to assess the postprandial glycaemic, insulinaemic and appetite responses to porridge made with oats processed differently.

Condition or disease Intervention/treatment Phase
Postprandial Glycaemia, Postprandial Insulinaemia Appetite Drug: Test meal Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 13 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Glycaemic, Insulinaemic and Appetite Responses to Two Different Types of Porridge
Study Start Date : October 2010
Actual Primary Completion Date : April 2011
Actual Study Completion Date : April 2011

Arm Intervention/treatment
Experimental: Pinhead oat porridge Drug: Test meal
Porridge made from rolled, or pinhead oats providing 50 g of carbohydrate

Experimental: Rolled oat porridge Drug: Test meal
Porridge made from rolled, or pinhead oats providing 50 g of carbohydrate




Primary Outcome Measures :
  1. Blood glucose [ Time Frame: Measured at baseline, 15, 30, 45, 60, 90 and 120 min after ingestion of a test meal ]

Secondary Outcome Measures :
  1. Plasma insulin [ Time Frame: Measured at baseline, 15, 30, 45, 60, 90 and 120 min after ingestion of a test meal ]
  2. Subjective appetite ratings [ Time Frame: Measured at baseline, 15, 30, 45, 60, 90 and 120 min after ingestion of a test meal ]
    Measured by a visual analogue scale (VAS)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 40 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Healthy
  • Aged 18-40 years

Exclusion Criteria:

  • Food allergies
  • Metabolic disorders

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01222845


Locations
United Kingdom
Brain, Performance and Nutrition Centre, Northumbria University
Newcastle Upon Tyne, Tyne and Wear, United Kingdom, NE1 8ST
Sponsors and Collaborators
Northumbria University
Investigators
Principal Investigator: Emma J Stevenson, PhD Northumbria University

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Javier Gonzalez, PhD Student, Northumbria University
ClinicalTrials.gov Identifier: NCT01222845     History of Changes
Other Study ID Numbers: 32W4
First Posted: October 18, 2010    Key Record Dates
Last Update Posted: May 2, 2012
Last Verified: May 2012